Table 3 Demographics and characteristics of patients with type 2 diabetes.

From: Investigating the Role of Myeloperoxidase and Angiopoietin-like Protein 6 in Obesity and Diabetes

 

Non-obese (n = 36)

Obese (n = 65)

p-value

Age

55.00 (47.75–58.00)

53.00 (49.00–57.00)

0.95

Gender (Male)

20 (55.6%)

34 (52.3%)

0.92

BMI

27.21 (25.21–28.95)

34.19 (32.67–35.72)

<0.001

Waist/Hip Ratio

0.93 (0.87–0.97)

0.95 (0.91–1.02)

0.08

TC (mmol/L)

4.50 (3.85–5.65)

4.90 (4.02–5.82)

0.47

HDL (mmol/L)

1.04 (0.90–1.21)

1.11 (0.88–1.33)

0.56

LDL (mmol/L)

2.75 (2.02–3.70)

3.05 (2.09–3.90)

0.91

TGL (mmol/L)

1.32 (0.80–1.90)

1.38 (1.10–1.88)

0.43

FPG (mmol/L)

6.70 (5.70–8.70)

7.30 (6.40–10.40)

<0.05

HbA1c (DCCT %)

6.40 (5.90–7.60)

8.15 (6.80–9.15)

<0.001

Insulin (mIU/L)

17.51 (8.95–31.03)

15.49 (7.88–26.16)

0.69

Adiponectin (μg/mL)

2.93 (1.94–3.87)

3.33 (1.91–4.98)

0.43

Leptin (ng/mL)

5.81 (3.14–8.10)

7.85 (5.36–10.88)

<0.05

PAI-1 (ng/mL)

16.37 (14.92–20.98)

13.85 (11.69–17.43)

<0.05

IL-6 (pg/mL)

18.47 (15.95–21.95)

16.54 (13.96–20.27)

0.15

TNF alpha (pg/mL)

140.41 (125.35–168.66)

117.61 (105.84–146.38)

<0.01

hsCRP(μg/mL)

1.67 (0.74–4.75)

3.59 (2.07–7.79)

<0.001

Hypertension

18 (50.0%)

39 (60.0%)

0.45

Hyperlipidemia

13 (36.1%)

21 (32.3%)

0.87

  1. Median (IQR) presented for continuous variables and N (%) presented for categorical variables. P values were calculated using Mann–Whitney U test for continuous variables and chi-squared test for categorical variables. BMI, body mass index; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; hsCRP, high sensitivity c-reactive protein; IL-6, interleukin-6; LDL, low-density lipoprotein; PAI-1, plasminogen activator inhibitor-1; TGL, triglycerides; TNF alpha, tumor necrosis factor alpha.
Back to article page